INH-A21: a donor-selected Staphylococcal human immune globulin for the prevention of late-onset neonatal Staphylococcal infection
- 30 May 2006
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 15 (6) , 703-707
- https://doi.org/10.1517/13543784.15.6.703
Abstract
INH-A21 is an experimental human immune globulin for intravenous infusion (IGIV) derived from donors specifically selected for elevated levels of antibodies against the Staphylococcal fibrinogen-binding proteins, serine aspartate dipeptide repeat G and clumping factor A. Phase II results demonstrated that infusions of INH-A21 were well tolerated and there were no trends for increasing adverse events, or the common morbidities associated with prematurity. Enrolment has been completed in (but no results have been released from) a Phase III human trial testing INH-A21 as a prophylactic agent against staphylococcal infection in very low birth weight infants (500 – 1250 g).Keywords
This publication has 17 references indexed in Scilit:
- Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In VivoAntimicrobial Agents and Chemotherapy, 2006
- Multicenter Study To Determine Antibody Concentrations and Assess the Safety of Administration of INH-A21, a Donor-Selected Human Staphylococcal Immune Globulin, in Low-Birth-Weight InfantsAntimicrobial Agents and Chemotherapy, 2005
- The Emergence of Decreased Susceptibility to Vancomycin in Staphylococcus epidermidisInfection Control & Hospital Epidemiology, 1999
- Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infantsThe Pediatric Infectious Disease Journal, 1998
- Effect of immunoglobulin therapy on phagocytosis by polymorphonuclear leucocytes in whole blood of neonatesClinical and Experimental Immunology, 1997
- Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin ProphylaxisPediatrics, 1997
- Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research NetworkThe Journal of Pediatrics, 1996
- Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses.Archives of Disease in Childhood: Fetal & Neonatal, 1995
- MSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUESAnnual Review of Microbiology, 1994
- Effect of an Intravenous Gammaglobulin Preparation on the Opsonophagocytic Activity of Preterm Serum against Coagulase‐Negative StaphylococciActa Paediatrica, 1990